2 Stocks Under Fire: MacroGenics and Vicor Face Class Action Lawsuits - Investors Beware!

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- In a shocking turn of events, two prominent companies, MacroGenics and Vicor, are facing class action lawsuits filed on behalf of their investors. This news has sent shockwaves throughout the financial community, leaving many to wonder what this means for their investments and the future of these companies.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, has issued a reminder to investors that class actions have been commenced against MacroGenics, Inc. (NASDAQ: MGNX) and Vicor Corporation (NASDAQ: VICR). The firm encourages investors to contact them to learn more about the cases and to discuss their rights and options.

Investors who have purchased shares of either MacroGenics or Vicor may be eligible to participate in these class action lawsuits. In order to do so, they must petition the court to serve as lead plaintiff before the specified deadlines. It is crucial for investors to act quickly, as these deadlines are fast approaching.

MacroGenics, Inc. (NASDAQ: MGNX) is a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of various diseases. The company has been making headlines in recent years with its promising pipeline of treatments, but this class action lawsuit may cast a shadow over its future prospects.

Vicor Corporation (NASDAQ: VICR), on the other hand, is a leading provider of power conversion solutions for a wide range of industries. The company has been experiencing rapid growth in recent years, but this lawsuit may put a damper on its momentum.

Both MacroGenics and Vicor have been listed on the NASDAQ stock exchange, which means that thousands of investors have a stake in these companies. The class action lawsuits have the potential to impact not only the companies themselves but also the investors who have placed their trust and money in them.

Investors who are concerned about their investments and want to learn more about the class action lawsuits against MacroGenics and Vicor can contact Bragar Eagel & Squire, P.C. to discuss their options. The firm's experienced team of attorneys is dedicated to fighting for the rights of investors and ensuring that they receive fair compensation for any losses incurred.

For more information about these class action lawsuits and to contact Bragar Eagel & Squire, P.C., investors can visit the firm's website. The website provides additional information about each case, including the deadlines for petitioning the court to serve as lead plaintiff.